ERA Biotech Raises VC

ERA Biotech, a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Barcelona, Spain-based company focused on improving the manufacturing of of recombinant proteins in cultured cellshas raised Euro 1.4 million in convertible note funding. Participants included Invertec, Reus Capital Riesgo, Talde Capial II and Uninvest. www.erabiotech.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />